Welcure Drugs Reports Q3 FY26 Results; Profit After Tax Reaches ₹106.67 Lakhs
Welcure Drugs & Pharmaceuticals Ltd · Financial Result · 13 Feb 2026, 1:06 am
Welcure Drugs Reports Q3 FY26 Results; Profit After Tax Reaches ₹106.67 Lakhs Welcure Drugs and Pharmaceuticals reported unaudited financial results for Q3 FY26, posting a profit after tax of ₹106.67 lakhs. Total income for the quarter ended 31st Dec’25 stood at ₹146.43 lakhs, a significant QoQ decline from ₹6,562.40 lakhs. However, PAT grew 157% YoY from ₹41.50 lakhs. Profit before tax was ₹142.55 lakhs. The auditor's limited review report included a disclaimer of opinion, noting an inability to obtain sufficient evidence for their conclusion on the financial statements.
Original exchange filing (PDF)
More announcements from Welcure Drugs & Pharmaceuticals Ltd
- Approval of the Audited Standalone Financial Results and Audited Standalone Financial Statements · 02 Nov 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd held on today i.e. Tuesday, 14th July, 2026. · 14 Jul 2026
- Resignation of Company Secretary and Compliance Officer · 19 Jun 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on Today i.e. Friday, 19th June, 2026 · 19 Jun 2026
- Audited Standalone Financial Results for the Quarter and Year Ended 31st March, 2026 · 30 May 2026
- Outcome of the Meeting of Board of Directors of the Company held on today i.e. Friday, 29th May, 2026 · 30 May 2026
- Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial .... · 29 May 2026
- <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> .... · 23 Apr 2026
